Physician profile
Ginger M Sims
NPI 1902866866
$644.32
in general payments reported to CMS, 2019-2025
11 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $141 · 2022: $209 · 2023: $49.11 · 2024: $130 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $294.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $145.20 | 2022-2023 | Prolia, Evenity |
| Boston Scientific Corporation | $127.77 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $115.69 | 2025 | Opsumit, Uptravi |
| Abbott Laboratories | $114.90 | 2024 | Eterna |
| Si-Bone, INC. | $40.30 | 2022-2023 | |
| Mylan Specialty L.P. | $28.46 | 2022-2023 | Yupelri |
| Vertos Medical, INC. | $18.82 | 2022 | |
| Radius Health, INC. | $15.00 | 2024 | |
| Merck Sharp & Dohme LLC | $13.35 | 2022 | |
| Nevro Corp. | $12.76 | 2021 | |
| Gilead Sciences, INC. | $12.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ginger Sims listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.